Precedentes romanos sobre el derecho ambiental : la contaminación de aguas, canalización de las aguas fecales y la tala ilícita forestal /

di Zamora Manzano, José Luis
Pubblicazione 2003

Reflections on adjuvant treatment of gastric cancer

di Abad, Albert, Manzano, José Luis, Martí, Cristina
Pubblicazione 2007

Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance

di Martinez-Cardús, Anna, Vizoso, Miguel, Moran, Sebastian, Manzano, Jose Luis
Pubblicato in Ann Transl Med (2015)

Appendiceal mixed adenoneuroendocrine carcinomas, a rare entity that can present as a Krukenberg tumor: case report and review of the literature

di Romeo, Margarita, Quer, Ariadna, Tarrats, Antoni, Molina, Carlos, Radua, Joaquim, Manzano, José-Luís
Pubblicato in World J Surg Oncol (2015)

Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM)

di Espinosa, Enrique, Márquez-Rodas, Ivan, Soria, Ainara, Berrocal, Alfonso, Manzano, Jose Luis, Gonzalez-Cao, Maria, Martin-Algarra, Salvador
Pubblicato in Ann Transl Med (2017)

Highlights of the season 2016–2017 by the Spanish Melanoma Group (GEM)

di Soria, Ainara, Manzano, Jose Luis, Berrocal, Alfonso, Espinosa, Enrique, Marquez-Rodas, Ivan, Gonzalez-Cao, Maria, Martin-Algarra, Salvador
Pubblicato in Ann Transl Med (2017)

Resistant mechanisms to BRAF inhibitors in melanoma

di Manzano, José Luís, Layos, Laura, Bugés, Cristina, de los Llanos Gil, María, Vila, Laia, Martínez-Balibrea, Eva, Martínez-Cardús, Anna
Pubblicato in Ann Transl Med (2016)

Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents

di Antelo, Gabriela, Hierro, Cinta, Fernández, Juan Pablo, Baena, Eduardo, Bugés, Cristina, Layos, Laura, Manzano, José Luis, Caro, Mónica, Mesia, Ricard
Pubblicato in Drugs Context (2020)

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines

di Ginés, Alba, Bystrup, Sara, Ruiz de Porras, Vicenç, Guardia, Cristina, Musulén, Eva, Martínez-Cardús, Anna, Manzano, José Luis, Layos, Laura, Abad, Albert, Martínez-Balibrea, Eva
Pubblicato in PLoS One (2015)

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

di Capdevila, Jaume, Teulé, Alexandre, Barriuso, Jorge, Castellano, Daniel, Lopez, Carlos, Manzano, Jose Luis, Alonso, Vicente, García‐Carbonero, Rocío, Dotor, Emma, Matos, Ignacio, Custodio, Ana, Casanovas, Oriol, Salazar, Ramon
Pubblicato in Oncologist (2018)

Enhancement of Antiviral CD8(+) T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab

di Blanch-Lombarte, Oscar, Gálvez, Cristina, Revollo, Boris, Jiménez-Moyano, Esther, Llibre, Josep M., Manzano, José Luís, Boada, Aram, Dalmau, Judith, E. Speiser, Daniel, Clotet, Bonaventura, G. Prado, Julia, Martinez-Picado, Javier
Pubblicato in J Clin Med (2019)

Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway

di Ruiz de Porras, Vicenç, Bystrup, Sara, Martínez-Cardús, Anna, Pluvinet, Raquel, Sumoy, Lauro, Howells, Lynne, James, Mark I., Iwuji, Chinenye, Manzano, José Luis, Layos, Laura, Bugés, Cristina, Abad, Albert, Martínez-Balibrea, Eva
Pubblicato in Sci Rep (2016)

Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients

di Ruiz de Porras, Vicenç, Bystrup, Sara, Cabrero-de las Heras, Sara, Musulén, Eva, Palomero, Luis, Alonso, Maria Henar, Nieto, Rocio, Arango, Diego, Moreno, Víctor, Queralt, Cristina, Manzano, José Luis, Layos, Laura, Bugés, Cristina, Martinez-Balibrea, Eva
Pubblicato in Cancers (Basel) (2019)

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

di Salazar, Ramon, Capdevila, Jaume, Laquente, Berta, Manzano, Jose Luis, Pericay, Carles, Villacampa, Mercedes Martínez, López, Carlos, Losa, Ferran, Safont, Maria Jose, Gómez, Auxiliadora, Alonso, Vicente, Escudero, Pilar, Gallego, Javier, Sastre, Javier, Grávalos, Cristina, Biondo, Sebastiano, Palacios, Amalia, Aranda, Enrique
Pubblicato in BMC Cancer (2015)

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

di Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, MªJosé, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada
Pubblicazione 2012

Phase II randomized trial of capecitabine with bevacizumab and external beam radiation therapy as preoperative treatment for patients with resectable locally advanced rectal adenoc...

di Salazar, Ramón, Capdevila, Jaume, Manzano, Jose Luis, Pericay, Carles, Martínez-Villacampa, Mercedes, López, Carlos, Losa, Ferrán, Safont, María José, Gómez-España, Auxiliadora, Alonso-Orduña, Vicente, Escudero, Pilar, Gallego, Javier, García-Paredes, Beatriz, Palacios, Amalia, Biondo, Sebastiano, Grávalos, Cristina, Aranda, Enrique
Pubblicato in BMC Cancer (2020)

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-secti...

di Capdevila, Jaume, Sevilla, Isabel, Alonso, Vicente, Antón Aparicio, Luís, Jiménez Fonseca, Paula, Grande, Enrique, Reina, Juan José, Manzano, José Luís, Alonso Lájara, Juan Domingo, Barriuso, Jorge, Castellano, Daniel, Medina, Javier, López, Carlos, Segura, Ángel, Carrera, Sergio, Crespo, Guillermo, Fuster, José, Munarriz, Javier, García Alfonso, Pilar
Pubblicato in BMC Cancer (2015)

Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials

di Benavides, Manuel, Díaz-Rubio, Eduardo, Carrato, Alfredo, Abad, Albert, Guillén, Carmen, Garcia-Alfonso, Pilar, Gil, Silvia, Cano, María Teresa, Safont, María José, Gravalos, Cristina, Manzano, José Luis, Sánchez, Antonio, Alcaide, Julia, López, Rafael, Massutí, Bartomeu, Sastre, Javier, Martínez, Eva, Escudero, Pilar, Méndez, Miguel, Aranda, Enrique
Pubblicato in ESMO Open (2019)

Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

di Gonzalez-Cao, Maria, Puertolas, Teresa, Riveiro, Mar, Muñoz-Couselo, Eva, Ortiz, Carolina, Paredes, Roger, Podzamczer, Daniel, Manzano, Jose Luis, Molto, Jose, Revollo, Boris, Carrera, Cristina, Mateu, Lourdes, Fancelli, Sara, Espinosa, Enrique, Clotet, Bonaventura, Martinez-Picado, Javier, Cerezuela, Pablo, Soria, Ainara, Marquez-Rodas, Ivan, Mandala, Mario, Berrocal, Alfonso
Pubblicato in J Immunother Cancer (2021)

Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)

di Gonzalez-Cao, Maria, Berrocal, Alfonso, Puig, Susana, Karachaliou, Niki, De Matos-Arruda, Leticia, Seoane, Joan, Escors, David, Alvarez, Carmen, Vaque, Jose Pedro, Prat, Aleix, Wellbrock, Claudia, Arozarena, Imanol, Marquez-Rodas, Ivan, Espinosa, Enrique, Molina, Migue Angel, Puertolas, Teresa, Juan-Otero, Manuel, Malagrida, Rosina, Jantus-Lewintre, Eloisa, Soriano, Virtudes, Arance, Ana, Manzano, Jose Luis, Lorigan, Paul, Gajewski, Thomas F., Rosell, Rafael, Martin-Algarra, Salvador
Pubblicato in Ann Transl Med (2017)